Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 2/20 | 0.43 |
| ▸ | CDK6 | Q00534 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.43 |
| ▸ | MAOA | P21397 | 4/20 | 0.39 |
| ▸ | MAOB | P27338 | 4/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | REN | P00797 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15855397 | 0.96 | CDK4 (0.41) | CDK4CDK6KDM4EATML3MBTL1 | |
| SCHEMBL15945625 | 0.96 | CDK4 (0.43) | CDK4CDK6KDM4EATML3MBTL1 | |
| SCHEMBL15945609 | 0.96 | KDM4E (0.47) | CDK4CDK6KDM4EATML3MBTL1 | |
| SCHEMBL15945680 | 0.94 | KDM4E (0.46) | CDK4CDK6KDM4EATML3MBTL1 | |
| SCHEMBL15945614 | 0.94 | KDM4E (0.44) | CDK4CDK6KDM4EATML3MBTL1 | |
| SCHEMBL15945627 | 0.94 | CDK4 (0.40) | CDK4CDK6KDM4EATML3MBTL1 | |
| SCHEMBL15945585 | 0.93 | KDM4E (0.53) | CDK4CDK6KDM4EATML3MBTL1 | |
| SCHEMBL15945584 | 0.93 | KDM4E (0.53) | CDK4CDK6KDM4EATML3MBTL1 | |
| SCHEMBL25946458 | 0.93 | KDM4E (0.44) | CDK4CDK6KDM4EATML3MBTL1 | |
| SCHEMBL12114929 | 0.93 | KDM4E (0.44) | CDK4CDK6KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9627629-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-04-18 | — | — | US | disclosed |
| US-9627629-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-04-18 | — | — | US | disclosed |
| US-20140225088-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES INC. (KR) | 2014-08-14 | — | — | US | disclosed |
| US-20140225088-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES INC. (KR) | 2014-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140225088-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | OR10J3, AOX1, NR2E3 | CDK4 226/4885CDK6 1565/4885KDM4E 2599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.